When stratifying for dose of chemotherapy, there was a trend for a decreased EFS with sarcopenia in the full dose group (p=0.095) but it did not reach statistical significance.
1
—
—
When stratifying for dose of chemotherapy, there was a trend for a decreased EFS with sarcopenia in the full dose group (p=0.095) but it did not reach statistical significance.